Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Research Data Declines Rapidly with Article age

By BiotechDaily International staff writers
Posted on 30 Dec 2013
A new study reveals that the vast majority of raw data from old studies is missing, making the reproducibility of results, a cornerstone of science, unavailable.

Researchers at the University of British Columbia (Vancouver, Canada), Université Laval (Canada), and other institutions requested data sets from the authors of a relatively homogenous set of 516 articles published between 2 and 22 years ago, finding that the availability of the data was strongly affected by article age. For papers where the authors gave the status of their data, the odds of a data set being extant fell by 17% per year. As a result, more 90% of the oldest data were inaccessible, and even in papers published as recently as 2011, they were only able to track down the data for 23% of the studies.

In addition, the odds that the researchers could even locate a working e-mail address for the first, last, or corresponding author fell by 7% per year. Defunct addresses were listed on the paper itself, with web searches not turning up any current ones. For another 38% of studies, the researcher’s queries led to no response. And even when they received a reply, access to another7% of the data sets was inaccessible, or the data itself was lost. The study was published on December 19, 2013, in Current Biology.

“Everybody kind of knows that if you ask a researcher for data from old studies, they’ll hem and haw, because they don’t know where it is,” said lead author zoologist Timothy Vines, PhD, of the University of British Columbia. “Some of the time, for instance, it was saved on three-and-a-half inch floppy disks, so no one could access it, because they no longer had the proper drives.”

“Because the basic idea of keeping data is so that it can be used by others in future research, this sort of obsolescence essentially renders the data useless,” added Dr. Vines. “Our results reinforce the notion that, in the long term, research data cannot be reliably preserved by individual researchers, and further demonstrate the urgent need for policies mandating data sharing via public archives.”

Preserving raw data is important because it is impossible to predict in which directions research will move in the future. Dr. Vines, for instance, has been conducting research on a pair of toad species native to Eastern Europe that seem to be in the process of hybridizing. In the 1980s, a separate team of researchers was working on the same topic, and came across an old paper written in Polish that documented the distribution of the toads in the 1930s. Knowing that their distribution had changed relatively little over the intervening decades allowed the scientists to make calculations that would not have been possible otherwise.

Related Links:

University of British Columbia
Université Laval



Channels

Genomics/Proteomics

view channel
Image: In mice, mitochondria (green) in healthy (left) and Mfn1-deficient heart muscle cells (center) are organized in a linear arrangement, but the organelles are enlarged and disorganized in Mfn2-deficient cells (right) (Photo courtesy of the Rockefeller Press).

Cell Biologists Find That Certain Mitochondrial Diseases Stem from Coenzyme Q10 Depletion

A team of German cell biologists has linked the development of certain mitochondrial-linked diseases to depletion of the organelles' pool of coenzyme Q10 brought about by mutation in the MFN2 gene, which... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.